# Extreme Networks Inc: Form 10-Q for the period ended Mar 31, 2019

- Company: [Extreme Networks Inc](/companies/extr.md) (CIK 1078271)
- Form: 10-Q
- Filed: 2019-05-10
- Accepted by EDGAR: May 10, 2019, 16:36 ET
- Period: 2019-03-31
- Accession: 0001564590-19-018574
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1078271/000156459019018574/extr-10q_20190331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1078271/000156459019018574/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-01-01 to 2019-03-31 | $250.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-07-01 to 2019-03-31 | $743.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-01-01 to 2019-03-31 | $111.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2018-07-01 to 2019-03-31 | $331.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-01-01 to 2019-03-31 | $138.9m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-07-01 to 2019-03-31 | $412.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-01-01 to 2019-03-31 | $52.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2018-07-01 to 2019-03-31 | $155.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-01-01 to 2019-03-31 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-07-01 to 2019-03-31 | −$2.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-01-01 to 2019-03-31 | $3.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2018-07-01 to 2019-03-31 | $9.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-01-01 to 2019-03-31 | $1.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-07-01 to 2019-03-31 | −$2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-01-01 to 2019-03-31 | −$6.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2018-07-01 to 2019-03-31 | −$8.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-01-01 to 2019-03-31 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-07-01 to 2019-03-31 | −$0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-01-01 to 2019-03-31 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-07-01 to 2019-03-31 | −$0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-01-01 to 2019-03-31 | 117,944,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-07-01 to 2019-03-31 | 117,619,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-07-01 to 2019-03-31 | $79.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-07-01 to 2019-03-31 | $16.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2018-07-01 to 2019-03-31 | $15.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-03-31 | $156.8m | us-gaap:Cash |
| Current assets | at 2019-03-31 | $390.6m | us-gaap:AssetsCurrent |
| Total assets | at 2019-03-31 | $711.5m | us-gaap:Assets |
| Current liabilities | at 2019-03-31 | $302.7m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2019-03-31 | $172.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-03-31 | $9.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2019-03-31 | $126.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1078271/000156459019018574/extr-10q_20190331.htm

Filed May 10, 2019.
Source: SEC EDGAR, the filing index for accession 0001564590-19-018574. Last ingested by Listed: Nov 6, 2026, 18:19 ET. No prices; not investment advice.
